Metagenomi, Inc.
SEC CIK 1785279 · MGX · last insider filing 2026-06-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bjerkholt Eric | Director | filed 2025 - 2026 |
| Dere Willard H | Director | filed 2024 - 2026 |
| Reid Laurence | Director | filed 2025 - 2026 |
| Eckhardt Juergen | Director | filed 2024 - 2026 |
| Irish Jian | Director · See Remarks | filed 2024 - 2026 |
| Thomas Brian C. | Director · Chief Executive Officer | filed 2024 - 2025 |
| Bernales Sebastian | Director | filed 2024 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wapnick Pamela | Chief Financial Officer | filed 2024 - 2026 |
| Wein Matthew | See Remarks | filed 2024 - 2026 |
| Noonberg Sarah B. | Chief Medical Officer | filed 2024 - 2025 |
| Borges Luis | Chief Scientific Officer | filed 2024 - 2024 |
| Harnest Simon | See Remarks | filed 2024 - 2024 |
| Delaney Simren | See Remarks | filed 2024 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.